tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ORIC Stock Latest News

Positive Growth Outlook for Oric Pharmaceuticals Driven by Clinical Catalysts and Financial Stability
RatingsPositive Growth Outlook for Oric Pharmaceuticals Driven by Clinical Catalysts and Financial Stability
5h ago
ORIC
Oric Pharmaceuticals reports Q4 EPS (51c), consensus (51c)
PremiumThe Fly
Oric Pharmaceuticals reports Q4 EPS (51c), consensus (51c)
3d ago
ORIC
Oric Pharmaceuticals announces upcoming milestones
PremiumThe Fly
Oric Pharmaceuticals announces upcoming milestones
3d ago
ORIC
Buy Rating on Oric Pharmaceuticals: Capitalizing on Prostate Cancer Treatment Advances
PremiumRatings
Buy Rating on Oric Pharmaceuticals: Capitalizing on Prostate Cancer Treatment Advances
7d ago
ORIC
Oric recent weakness a buying opportunity, says JPMorgan
PremiumThe Fly
Oric recent weakness a buying opportunity, says JPMorgan
10d ago
PFE
ORIC
Promising Efficacy and Manageable Safety of ORIC-944 Positions ORIC Shares Favorably
PremiumRatingsPromising Efficacy and Manageable Safety of ORIC-944 Positions ORIC Shares Favorably
10d ago
ORIC
Positive Outlook for Oric Pharmaceuticals Driven by Promising Trial Results of Mevrometostat and Xtandi Combination
Premium
Ratings
Positive Outlook for Oric Pharmaceuticals Driven by Promising Trial Results of Mevrometostat and Xtandi Combination
10d ago
ORIC
Oric Pharmaceuticals: Promising Trials and Strong Financials Justify Buy Rating
Premium
Ratings
Oric Pharmaceuticals: Promising Trials and Strong Financials Justify Buy Rating
11d ago
ORIC
Cantor says Oric accidental release looks ‘very positive’ for mevrometostat
PremiumThe Fly
Cantor says Oric accidental release looks ‘very positive’ for mevrometostat
11d ago
ORIC
Optimistic Buy Rating for Oric Pharmaceuticals Driven by Promising Data and Favorable Risk/Reward Profile
PremiumRatings
Optimistic Buy Rating for Oric Pharmaceuticals Driven by Promising Data and Favorable Risk/Reward Profile
11d ago
ORIC
Buy Rating Affirmed for Oric Pharmaceuticals Amid Promising Trial Data and Market Projections
PremiumRatings
Buy Rating Affirmed for Oric Pharmaceuticals Amid Promising Trial Data and Market Projections
16d ago
ORIC
Oric Pharmaceuticals trial results ‘highly encouraging,’ says H.C. Wainwright
PremiumThe Fly
Oric Pharmaceuticals trial results ‘highly encouraging,’ says H.C. Wainwright
1M ago
ORIC
Oric Pharmaceuticals to Present at J.P. Morgan Conference
PremiumCompany AnnouncementsOric Pharmaceuticals to Present at J.P. Morgan Conference
1M ago
8K
ORIC
Oric Pharmaceuticals provides early Phase 1b combination data for ORIC-944
Premium
The Fly
Oric Pharmaceuticals provides early Phase 1b combination data for ORIC-944
1M ago
ORIC
Oric Pharmaceuticals sees cash runway into late 2026
Premium
The Fly
Oric Pharmaceuticals sees cash runway into late 2026
1M ago
ORIC
Oric Pharmaceuticals announces clinical supply agreement with Janssen
PremiumThe Fly
Oric Pharmaceuticals announces clinical supply agreement with Janssen
1M ago
JNJ
ORIC
Oric Pharmaceuticals Reports Strong Financial Growth and Clinical Progress
PremiumCompany Announcements
Oric Pharmaceuticals Reports Strong Financial Growth and Clinical Progress
3M ago
ORIC
Oric Pharmaceuticals reports Q3 EPS (49c), consensus (48c)
PremiumThe Fly
Oric Pharmaceuticals reports Q3 EPS (49c), consensus (48c)
3M ago
ORIC
ORIC Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ORIC Earnings this Week: How Will it Perform?
4M ago
ORIC
Wingstop upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls
PremiumThe FlyWingstop upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls
4M ago
EL
RF
Wells starts Oric Pharmaceuticals with Overweight into ‘de-risking catalysts’
Premium
The Fly
Wells starts Oric Pharmaceuticals with Overweight into ‘de-risking catalysts’
4M ago
ORIC
Oric Pharmaceuticals initiated with an Overweight at Wells Fargo
Premium
The Fly
Oric Pharmaceuticals initiated with an Overweight at Wells Fargo
4M ago
ORIC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >